PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins.
Ontology highlight
ABSTRACT: Neurodegenerative diseases are an enormous public health problem, affecting tens of millions of people worldwide. Nearly all of these diseases are characterized by oligomerization and fibrillization of neuronal proteins, and there is great interest in therapeutic targeting of these aggregates. Here, we show that soluble aggregates of α-synuclein and tau bind to plate-immobilized PrP in vitro and on mouse cortical neurons, and that this binding requires at least one of the same N-terminal sites at which soluble Aβ aggregates bind. Moreover, soluble aggregates of tau, α-synuclein and Aβ cause both functional (impairment of LTP) and structural (neuritic dystrophy) compromise and these deficits are absent when PrP is ablated, knocked-down, or when neurons are pre-treated with anti-PrP blocking
SUBMITTER: Corbett GT
PROVIDER: S-EPMC7035229 | biostudies-literature | 2020 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA